CYP17A1 and atherosclerosis: In consistent with cellular results, CYP17A1 knockout mice, apparent impaired glucose tolerance, insulin resistance, corresponding changes in the levels of hormones, accelerated vascular endothelial injury and promoted formation of atherosclerosis.